CIMINO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.829
AS - Asia 7.343
EU - Europa 4.810
SA - Sud America 1.736
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 213
OC - Oceania 41
Totale 38.235
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.247
SG - Singapore 2.072
CN - Cina 1.560
HK - Hong Kong 1.391
BR - Brasile 1.321
IT - Italia 1.159
GB - Regno Unito 1.057
VN - Vietnam 869
FI - Finlandia 601
SE - Svezia 493
BD - Bangladesh 380
CA - Canada 332
RU - Federazione Russa 303
DE - Germania 300
KR - Corea 206
FR - Francia 174
IN - India 162
BG - Bulgaria 159
AR - Argentina 137
NL - Olanda 133
ID - Indonesia 125
UA - Ucraina 124
TR - Turchia 114
JP - Giappone 99
EC - Ecuador 70
IQ - Iraq 70
EG - Egitto 61
MX - Messico 60
ES - Italia 56
AT - Austria 49
CO - Colombia 46
ZA - Sudafrica 46
CL - Cile 45
PL - Polonia 44
PE - Perù 39
AU - Australia 31
AE - Emirati Arabi Uniti 30
MY - Malesia 30
IE - Irlanda 29
PK - Pakistan 29
VE - Venezuela 29
JM - Giamaica 25
MA - Marocco 25
CR - Costa Rica 24
PY - Paraguay 23
UZ - Uzbekistan 22
CZ - Repubblica Ceca 21
IL - Israele 20
TT - Trinidad e Tobago 20
TH - Thailandia 19
UY - Uruguay 19
HN - Honduras 18
SA - Arabia Saudita 18
DZ - Algeria 17
KW - Kuwait 17
TN - Tunisia 17
BZ - Belize 16
GT - Guatemala 16
KE - Kenya 16
PR - Porto Rico 16
LT - Lituania 15
NP - Nepal 14
SV - El Salvador 14
AL - Albania 12
PH - Filippine 11
TW - Taiwan 11
BE - Belgio 10
PT - Portogallo 10
DK - Danimarca 9
NI - Nicaragua 9
RO - Romania 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
IR - Iran 8
KZ - Kazakistan 8
AZ - Azerbaigian 7
JO - Giordania 7
SI - Slovenia 7
BO - Bolivia 6
MN - Mongolia 6
NZ - Nuova Zelanda 6
PA - Panama 6
CY - Cipro 5
EU - Europa 5
KG - Kirghizistan 5
OM - Oman 5
BS - Bahamas 4
ET - Etiopia 4
GE - Georgia 4
MK - Macedonia 4
NO - Norvegia 4
AO - Angola 3
BB - Barbados 3
BH - Bahrain 3
EE - Estonia 3
GP - Guadalupe 3
HU - Ungheria 3
LB - Libano 3
LV - Lettonia 3
LY - Libia 3
Totale 37.919
Salva come PNG Salva come JPEG
Città #
Stanford 9.026
Ashburn 1.949
Santa Clara 1.747
Hong Kong 1.373
Singapore 1.119
Fairfield 906
San Jose 785
Council Bluffs 567
Helsinki 558
Chandler 459
London 458
Houston 454
Woodbridge 443
Nyköping 386
Southend 364
Seattle 346
Beijing 333
Ho Chi Minh City 322
Wilmington 307
Cambridge 301
Los Angeles 264
The Dalles 254
New York 239
Ann Arbor 227
Hefei 213
Seoul 202
Hanoi 198
Jacksonville 174
Princeton 174
Toronto 167
Manassas 159
San Diego 153
Sofia 153
Modena 151
Milan 149
Dallas 144
Dearborn 139
São Paulo 123
Chicago 115
Buffalo 111
Moscow 101
Columbus 91
Port Wentworth 89
Boardman 80
Palo Alto 76
Rome 73
Lauterbourg 67
Shanghai 65
Capelle aan den IJssel 63
Jakarta 63
North Bergen 61
Saint Augustine 60
Tokyo 59
Nuremberg 53
Orem 51
Redondo Beach 50
Cairo 42
Washington 42
Frankfurt am Main 41
Rio de Janeiro 41
Eugene 40
Atlanta 36
Montreal 36
Salt Lake City 36
Guangzhou 35
Munich 35
Haiphong 34
Bologna 33
Phoenix 33
Brooklyn 32
Denver 31
Da Nang 30
Philadelphia 29
Brasília 27
Izmir 27
Warsaw 27
Lima 26
Amsterdam 25
Santiago 25
Vienna 25
Baghdad 24
Curitiba 24
Dublin 24
Quito 24
Reggio Emilia 24
Biên Hòa 23
Porto Alegre 23
Belo Horizonte 22
San Francisco 22
Turin 22
Melbourne 21
Paris 21
Bengaluru 20
Cleveland 20
Guayaquil 20
Naples 20
Charlotte 19
Florence 19
Mexico City 19
Palermo 19
Totale 28.032
Salva come PNG Salva come JPEG
Nome #
Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography 3.879
Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies 2.224
Acute zonal occult outer retinopathy complex disease: Lessons learned about choroid, photoreceptors, and retinal function 984
Choroidal Vascular Changes in Multiple Evanescent White Dot Syndrome 949
Differential inflammatory involvement in retina and choroid in birdshot chorioretinopathy 943
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 1: Guidelines for Initiating Antitubercular Therapy in Tubercular Choroiditis 885
Visual loss and other cranial ischaemic complications in giant cell arteritis 400
Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis—Report 2: Guidelines for Initiating Antitubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis, and Retinal Vasculitis 372
Assessment of the Anti-inflammatory Effects of NORFLO® ORO in Acute Relapses of HLA-B27-associated Autoimmune Uveitis: A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Study 351
-463 G/A myeloperoxidase promoter polymorphism in giant cell arteritis 349
G/R 241 polymorphism of intercellular adhesion molecule 1 (ICAM-1) is associated with Fuchs uveitis 314
Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study 310
Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis 302
Comparison between colour duplex sonography findings and different histological patterns of temporal artery 295
anti-TNF agents as therapeutic choice in immune-mediated inflammatory diseases: focus on adalimumab 291
Long-term remission in biopsy proven giant cell arteritis: A retrospective cohort study 289
Interferon Alpha-2a for the Treatment of Post-Infectious Uveitis Secondary to Presumed Intraocular Tuberculosis 286
Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study 285
Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis 282
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis 280
Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study 278
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial 276
Ophthalmic manifestations of cat scratch disease 276
Increased expression of interleukin-22 in patients with giant cell arteritis 271
Adalimumab in the treatment of immune-mediated diseases 269
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia 269
The causes of uveitis in a referral centre of Northern Italy 267
Histopathologic Findings of Patients With Biopsy-Negative Giant Cell Arteritis Compared to Those Without Arteritis: A Population-Based Study 266
Higher Frequencies of Lymphocytes Expressing the Natural Killer Group 2D Receptor in Patients With Behçet Disease 265
Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement 262
Association Between Specimen Length and Number of Sections and Diagnostic Yield of Temporal Artery Biopsy for Giant Cell Arteritis 261
Quasi cieco all'improvviso 255
Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features 248
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis 246
Small-vessel vasculitis surrounding an uninflamed temporal artery and isolated vasa vasorum vasculitis of the temporal artery: two subsets of giant cell arteritis 242
Clinical Relevance of Subcentimetric Lymph Node Biopsy in the Diagnosis of Ocular Sarcoidosis 239
Searching for viral antibodies and genome in intraocular fluids of patients with Fuchs uveitis and non-infectious uveitis 237
Tuberculous uveitis, a resurgent and underdiagnosed disease 237
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study 237
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 227
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma 226
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 3) 225
The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases 224
Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative 224
PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis 222
Interleukin-10 promoter polymorphisms in giant cell arteritis 222
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis 221
Anterior ischaemic optic neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a case report and review of the literature 221
Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the collaborative ocular tuberculosis study (COTS)-1 217
Reggio Emilia (Northern Italy) Interdisciplinary Uveitis Clinic: What We Have Learned in the Last 20 Years 216
The therapeutic potential of tuftsin-phosphorylcholine in giant cell arteritis 216
Erratum to: Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases (International Ophthalmology, (2017), 10.1007/s10792-016-0434-x) 212
Diagnosis and Treatment of Listeria monocytogenes Endophthalmitis: A Systematic Review 212
Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis? 210
Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise 210
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach 210
Ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (part 2) 208
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study 207
Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis 206
Uveitis and other ocular complications following covid-19 vaccination 198
Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis) 196
Cytokine Profiling in Aqueous Humor Samples From Patients With Non-Infectious Uveitis Associated With Systemic Inflammatory Diseases 191
Relapses and long-term remission in large vessel giant cell arteritis in northern Italy: Characteristics and predictors in a long-term follow-up study 187
Cataract Surgery with Intraocular Lens Implantation in Juvenile Idiopathic Arthritis-Associated Uveitis: Outcomes in the Era of Biological Therapy 187
Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop 187
Surgical management of post-uveitic epiretinal membranes 186
Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis 181
Primary inflammatory Choriocapillaropathies 180
Autoimmune uveitis in children: clinical correlation between antinuclear antibody positivity and ocular recurrences 180
Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography 178
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: A population-based study 178
Interferon Alpha-2a Treatment for Post-Uveitic Refractory Macular Edema 175
Toll-like receptor 4 (TLR4) gene polymorphisms in giant cell arteritis 172
Abatacept for Severe Anti-Tumor Necrosis Factor alpha Refractory Juvenile Idiopathic Arthritis-Related Uveitis 170
Eosinophilic giant cell arteritis: A different subset of disease? 165
Ocular vasculitis: a multidisciplinary approach 164
Vitreoretinal lymphomas misdiagnosed as uveitis: Lessons learned from a case series 164
Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment 163
Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors 161
Vogt–Koyanagi–Harada patients show higher frequencies of circulating NKG2Dpos NK and NK T cells 160
Fluorescein angiography findings in eyes with lamellar macular hole and epiretinal membrane foveoschisis 160
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy 159
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III 158
Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies 156
Interleukin-6 promoter polymorphism at position -174 in giant cell arteritis 155
Aqueous tap and rapid diagnosis of cytomegalovirus anterior uveitis: the Reggio Emilia experience 152
Role of miR-146a and miR-146b in Giant Cell Arteritis. 151
Corrigendum to: Increased expression of interleukin-22 in patients with giant cell arteritis 151
Insight into giant cell arteritis pathogenesis by NanoString nCounter gene expression profiling in temporal artery biopsies 150
Assessement and classification of choroidal vasculitis in intraocular inflammation using indocyanine green angiography 148
Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome 148
Infantile-Onset Spinocerebellar Ataxia Type 5 (SCA5) with Optic Atrophy and Peripheral Neuropathy 146
Improvement of spatial contrast sensitivity threshold after surgical reduction of intraocular pressure in unilateral high-tension glaucoma 145
Interleukin-6 expression in inflamed and non-inflamed temporal arteries from patients with giant cell arteritis 144
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN ENDOGENOUS CANDIDA ENDOPHTHALMITIS AND THEIR CLINICAL RELEVANCE 142
Anterior Chamber Inflammation After Cataract Surgery: A Randomized Clinical Trial Comparing Bromfenac 0.09% to Dexamethasone 0.1% 142
Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases 141
Yag laser iridotomy in pigment dispersion syndrome: 10 years later 141
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis 139
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings 138
Totale 30.196
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.629 0 0 0 58 19 67 449 59 197 53 443 284
2022/20231.776 278 178 176 93 147 219 34 171 203 23 110 144
2023/20241.788 35 73 74 100 390 131 66 225 296 97 56 245
2024/20255.374 95 46 75 337 1.158 840 495 239 685 294 330 780
2025/202612.919 556 376 1.082 1.538 904 701 1.297 801 937 876 974 2.877
2026/202710.636 6.856 979 1.175 1.626 0 0 0 0 0 0 0 0
Totale 38.235